Last Updated : May 6, 2013
Details
FilesGeneric Name:
Rivaroxaban
Project Status:
Complete
Therapeutic Area:
Venous thromboembolic events, pulmonary embolism
Manufacturer:
Bayer Inc.
Call for patient/clinician input open:
Brand Name:
Xarelto
Project Line:
Reimbursement Review
Project Number:
SR0327-000
Call for patient/clinician input closed:
Performance Metric:
N/A — Predated performance metrics
Submission Type:
Initial
Indications:
Thromboembolic events (venous), pulmonary embolism
Recommendation Type:
List with criteria/condition
Final Recommendation:
Files
Last Updated : May 6, 2013